Approval · Notice of Compliance 35150 · 2025
ELYXYB: Notice of Compliance 35150
Issued April 9, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35150
- Date
- April 9, 2025
- Company
- Scilex Pharmaceuticals Inc.Palo Alto, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELYXYB | 02556804 | Approved |
Medicinal ingredients
- CELECOXIB 120 MG per 4.8ML